Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 319-325, April 2010

Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery☆

  • Jiucheng He
    • ,
  • Haydee E.P. Bazan

      Affiliations

    • Corresponding Author InformationCorrespondence to: LSU Health Sciences Center, 2020 Gravier Street, Suite D, New Orleans, LA 70112, USA. Tel.: +15045990877; fax: +15045685801.

Department of Ophthalmology and Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA

published online 04 March 2010.

Abstract 

Dry eye (DE) is a multifactorial condition that affects the surface of the eye and induces an inflammatory response. Corneal nerves play an important role in the maintenance of a healthy ocular surface. Here we review corneal structure, nerve architecture, DE conditions, and nerve regeneration following corneal surgery and discuss how n-3 fatty acids affect the health of the cornea. Animal studies show that resolvins, compounds derived from eicosapentaenoic acid (EPA), increase tear volume and decrease inflammation induced by DE. After corneal surgery in rabbits, treatment with nerve growth factor (NGF) or pigment epithelial derived factor (PEDF) in conjunction with docosahexaenoic acid (DHA) increase nerve density and corneal epithelial cell proliferation. Increased synthesis of the novel docosanoid, neuroprotectin D1 (NPD1), was found in corneas after the animals were treated with PEDF and DHA. Topical application of these lipids derived from n-3 fatty acids could be useful in treating DE and prevent clinical complications such as cornea erosion and ulcerations.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ The authors’ work described here was supported by National Institutes of Health, National Eye Institute grant R01 EY19465, by a Translational Research Initiative grant from the Lousiana State University Health Sciences Center, New Orleans, and by a grant from Resolvyx Pharmaceuticals, Bedford, Massachusetts.

PII: S0952-3278(10)00048-7

doi:10.1016/j.plefa.2010.02.004

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 319-325, April 2010

Article Tools

* Image Usage & Resolution